Kazia CEO, Dr James Garner discusses the recent positive interim data from the phase II trial of paxalisib in glioblastoma, COVID-19 and the company's recent capital raising
26-Jun-2019
Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2019 Gold Coast Investment Showcase
15-Apr-2019
Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the Wholesale Investor Emergence event in Brisbane.
11-Jul-2018
Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2018 Gold Coast Investment Showcase.
06-Apr-2018
Dr James Garner speaks with CommSec re our GDC-0084 Phase II trial start.
29-Mar-2018
NDF Research Senior Analyst Stuart Roberts interviews Kazia Therapeutics CEO Dr James Garner as the GDC-0084 phase II trial launches in the US.
30-Nov-2017
CommSec interview re our new name, Kazia Therapeutics and our clinical trial progress.
04-Jul-2017
CommSec Executive Series interviews CEO Dr James Garner on benefits of new business model for patients
19-May-2017
ASX CEO Session interview with FNN
1-May-2017
Dr James Garner, CEO, speaks to Canary Networks investment forum